Medtronic dropped -5.2% during today's afternoon session, underperforming the S&P 500 by -6.5%. The lackluster performance from the large-cap Medical Devices company may seem like an opportunity to buy shares at a discount, but it's a good idea to take a closer look at the company's cash flows first.
|Date Reported||Cash Flow from Operations ($)||Capital expenditures ($)||Free Cash Flow ($)||YoY Growth (%)|
The coefficient of variability of Medtronic's free cash flow is 9.5% and the average growth rate is 2.0. These metrics tell us that company's cash flows are strong and steady, which likely means that the company's management is effective in converting its profits into cash. Value minded investors may see today's dip as a welcome discount on MDT